WHITEFISH, MT / ACCESSWIRE / February 4, 2015 / Earth Science Tech (ETST) has been making excellent progress validating the efficacy of their proprietary CBD (cannabidiol) Rich Hemp Oil product lately via work done at the University of Central Oklahoma, carried out under the visionary eye of the university’s Assistant Dean of the College of Mathematics & Science, world-renown scientist and researcher Dr. Wei R. Chen. Following up on initial preliminary testingin animal breast cancer last year, which showed that the appropriate dosages could indeed inhibit cancer cell proliferation at a significant rate, subsequent research into the product’s ability to bolster the body’s immune system by stimulating the production of a key cytokine (TNF-alpha, a signaling protein) in macrophages (“big eater” white blood cells that engulf and digest things like microbes and cancer cells), has now produced promising results as well.

This important research, conducted under an ETST grant to study the anti-tumor effects of the product, has now also shown a marked ability of hemp oil enriched with CBD to enhance TNF-alpha (tumor necrosis factor-alpha) production when triggered by the potent activator LPD (lipopolysaccharide). This latest set of findings clears the way for forthcoming in vivo work designed to flesh-out how the product may be used to improve cancer treatments, as well as induce and augment anti-tumor immune response. This is an area of intense study within the medical community today and recent research high-water marks, like the clinical trial testing on GW Pharmaceuticals’ (GWPH) Epidiolex, a purified and formulated CBD investigational antiepileptic drug granted orphan drug status by the FDA, which is being conducted at Texas Children’s Hospital, is a prime example of just how real and potentially far-reaching the pharmaceutical applications of CBD are.

Other research conducted by GW Pharmaceuticals in the area of using cannabinoids like CBD for oncology, has shown measurable tumor response that is positively associated with increasing levels of the substance in tissues. Findings which broadly reinforce the work being done by Earth Science Tech, including GWPH’s identification of the ability of cannabinoids (like CBD and THC) to promote the re-emergence of apoptosis (biochemically signaled cell death) in cancer cells. Such ongoing work in cannabinoids for oncological and neurological disorder treatments, adds significant weight to the growing body of cannabinoid science that shows a wide range of physiological processes, including pain and inflammation, can be regulated via the body’s cannabinoid receptors. Companies like Cara Therapeutics (CARA) and Insys Therapeutics (INSY) are both in ongoing development of innovative cannabinoid treatments for neuropathic (chronic) pain, even as the broader medical and recreational marijuana retail market in the U.S. has recently been shown to have grown at the fastest pace of any industry in the country, according to a new report by ArcView Research, which indicated 74% growth last year for the sector to around $2.7 billion.

Earth Science Tech’s proprietary CBD Rich Hemp Oil product has the distinct market advantage of being legal in all 50 states and over 40 countries worldwide, thanks to the fact that it is a non-psychoactive and food-grade product, making it the perfect candidate for incorporation into a vast array of nutraceutical products. The company is continuing to make strides in setting itself up as a premier wholesale distributor of high-grade CBD and has continued to emphasize a decided openness to strategic partnerings, JVs and supply relationships with resellers or private label distributors, in order to maximize market impact of their rapidly developing portfolio. The company has spring boarded off their University of Central Oklahoma research into two provisional patents on CBD and CBD enhanced with proprietary additives (like D-limonene, which has shown synergistic anticancer advantages) for various uses, including treating or preventing cancer, and has put together a total of 10 new claims besides.

Earth Science Tech also has an important edge on the market via their wholly-owned Nutrition Empire subsidiary, whose flagship retail location opened its doors on December 15th, 2014 at an ideal in Coral Gables, Florida which is adjacent to one of South Florida’s most bustling entertainment destinations, Merrick Park. This is a high-end Miami hot spot and the Nutrition Empire store is advantageously located in the gorgeous Gables Ponce Complex, which is slated to have 1k apartments after current phase 3 development is complete, granting Nutrition Empire direct access to a stable clientele. This complex is at the epicenter of health and fitness for the area and is in range of multiple CrossFit locations, as well as the nearby University of Miami, and boasts a variety of complementary amenities, including a fitness center, pool, and spa services.

The Nutrition Empire store emphasizes competitive pricing and has a huge selection of the best in nutraceuticals, sports nutrition and dietary supplements, with over 550 products from 60 plus of the top developers. This initial store location is also the first retailer in the country to carry and prominently feature the company’s CBD Rich Hemp Oil product. Moreover, with the launch of online ordering via the Nutrition Empire website, customers have access to a dizzying array of over 6k SKUs of different nutritionals and dietary supplements from 300 of the most cutting-edge vendors in the industry today. This is a strong foundation for Earth Science Tech’s ongoing CBD roll out and R&D efforts, and brings a solid revenue stream to the equation, as well as a platform for putting newly developed CBD-based products directly into the hands of consumers, while generating valuable brand/product awareness.

Unlike companies such as Nature’s Sunshine Products (NASDAQ:NATR) or Herbalife (NYSE:HLF), which are largely focused on direct selling through independent distributors, Earth Science Tech is taking the more lucrative approach of doing their own web-enabled brick and mortar retail distribution, with the added benefit of looking to grow into a wholesale-focused distributor long-term.

With the U.S. nutraceutical market currently estimated as growing at an upwards of 6% CAGR through 2017, when the space is expected to exceed $75.3 billion according to the latest analysis published by Research and Markets, ETST’s Nutrition Empire subsidiary is tapping into a big growth market with a core product that already has high cachet value. With valuations on the global nutraceutical market anywhere from $241 billion (BCC Research) to $424 billion (Ken Research) within the next four years alone, Earth Science Tech has plenty of room to grow in international markets as well.

About CannabisFN:

Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating investors, profiling public companies, and developing specific investors audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and educates investors, business developers and media on industry news, thought leader and executive perspectives, and the fluid regulatory environment while serving as a leading corporate communications platform to public and private companies operating in the industry.

To learn how your company can be covered on CannabisFN, visithttps://www.cannabisfn.com/market-defining-companies-program/.

To subscribe to the CannabisFN weekly newsletter or read additional coverage on cannabis laws and investments, visit https://www.cannabisfn.com.

Legal Disclaimer:

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit:https://www.cannabisfn.com/legal-disclaimer/.

SOURCE: Cannabis Financial Network